Tan MSY - Search Results

Year	Number of Results
2012	1
2015	1
2016	1
2017	1
2018	3
2019	2
2020	7
2021	6
2022	1
2023	3
2024	3
2025	3

1

Tan MSY, Blackman MJ. Tan MSY, et al. J Cell Sci. 2021 Mar 8;134(5):jcs257345. doi: 10.1242/jcs.257345. J Cell Sci. 2021. PMID: 33686010 Free PMC article. Review.

2

Beyond BCMA: newer immune targets in myeloma.

Tan MSY, Chen Y, Smith EL. Tan MSY, et al. Blood Adv. 2024 Aug 27;8(16):4433-4446. doi: 10.1182/bloodadvances.2023010856. Blood Adv. 2024. PMID: 38865708 Free PMC article. Review.

3

T cell redirecting therapy for relapsed multiple myeloma.

Tan MSY, Hellou T, Dingli D. Tan MSY, et al. Discov Oncol. 2025 Aug 18;16(1):1573. doi: 10.1007/s12672-025-03432-z. Discov Oncol. 2025. PMID: 40824610 Free PMC article. Review.

4

Risk factors for pregnancy-associated venous thromboembolism in Singapore.

Jaya-Bodestyne SL, Lee LH, Tan LK, Tan KH, Østbye T, Malhotra R, Allen J, Tan SSX, Tan MSY, Ng LCK, Yong Y, Tan TC. Jaya-Bodestyne SL, et al. Among authors: tan msy. J Perinat Med. 2020 Sep 5;49(2):153-158. doi: 10.1515/jpm-2020-0298. Print 2021 Feb 23. J Perinat Med. 2020. PMID: 32889795 Free article.

5

The use of medium cutoff dialyzers in patients with multiple myeloma and acute kidney injury requiring hemodialysis: A systematic review.

Koniman R, Teo SH, Kaushik M, Nagarajan C, Tan MSY, Tan HK, Ramirez MEG, Lim CC; S.I.N:G.A.P.O.R.E Initiative (Science In Nephrology: Growth And Progress Of Research & Education). Koniman R, et al. Among authors: tan msy. Semin Dial. 2023 Jan;36(1):12-17. doi: 10.1111/sdi.13115. Epub 2022 Jul 15. Semin Dial. 2023. PMID: 35840146

6

Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent Lymphoma.

Tan CJ, Tan MSY, Nagarajan C, Chng WJ, Chee YL, Ooi M, Ng LCK, Chen Y, Yoong JSY, Wong XY, Jen WY. Tan CJ, et al. Among authors: tan msy. JCO Oncol Pract. 2023 Dec;19(12):1168-1178. doi: 10.1200/OP.23.00336. Epub 2023 Oct 16. JCO Oncol Pract. 2023. PMID: 37844267

7

Current perspectives on resistance to chimeric antigen receptor T-cell therapy and strategies to improve efficacy in B-cell lymphoma.

Ong SY, Chen Y, Tan MSY, Ho AYL, Hwang WYK, Lim FLWI. Ong SY, et al. Among authors: tan msy. Eur J Haematol. 2024 Feb;112(2):144-152. doi: 10.1111/ejh.13964. Epub 2023 Apr 3. Eur J Haematol. 2024. PMID: 36987995 Review.

8

Novel broad-spectrum activity-based probes to profile malarial cysteine proteases.

Tan MSY, Davison D, Sanchez MI, Anderson BM, Howell S, Snijders A, Edgington-Mitchell LE, Deu E. Tan MSY, et al. PLoS One. 2020 Jan 10;15(1):e0227341. doi: 10.1371/journal.pone.0227341. eCollection 2020. PLoS One. 2020. PMID: 31923258 Free PMC article.

9

A STAT3-based gene signature stratifies glioma patients for targeted therapy.

Tan MSY, Sandanaraj E, Chong YK, Lim SW, Koh LWH, Ng WH, Tan NS, Tan P, Ang BT, Tang C. Tan MSY, et al. Nat Commun. 2019 Aug 9;10(1):3601. doi: 10.1038/s41467-019-11614-x. Nat Commun. 2019. PMID: 31399589 Free PMC article.

10

Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.

Tan MSY, Koussis K, Withers-Martinez C, Howell SA, Thomas JA, Hackett F, Knuepfer E, Shen M, Hall MD, Snijders AP, Blackman MJ. Tan MSY, et al. EMBO J. 2021 Jun 1;40(11):e107226. doi: 10.15252/embj.2020107226. Epub 2021 May 1. EMBO J. 2021. PMID: 33932049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year